BridgeMD
Scar Remodeling after Burn Injury using Adipose-derived Allogeneic Stem Cells
EU CTIS ID: 2024-519160-41-00
What this study is testing
The objective is to investigate the potential therapeutic efficacy of allogeneic adipose-derived stem cells and autologous stromal vascular fraction on scar quality as compared to placebo.
- Phase I and Phase II (Integrated)- Other
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Adults ≥ 18 years of age
- Hypertrophic scars (age of scar > 2 years) after burn injuries on the front trunk or extremities.
- Three uniform 6 cm x 6 cm areas of burn scar tissue on the front of the thorax or extremities. The scar should be large enough to separate the areas with a minimum of two centimeters.
- BMI > 22 and enough abdominal fat for a minor liposuction.
- Ability to understand information about the project.
You likely can't join if
- Significant comorbidities or lack of cognitive abilities to follow instructions.
- Not being able to participate due to language or other personal issues.
- Contraindications for abdominal liposuction.
- Pregnancy or breastfeeding
- Current or previous steroid therapy (systemic or local) within one year.
- Scar revision surgery within one year in the affected areas.
See the full eligibility criteria
- Adults ≥ 18 years of age
- Hypertrophic scars (age of scar > 2 years) after burn injuries on the front trunk or extremities.
- Three uniform 6 cm x 6 cm areas of burn scar tissue on the front of the thorax or extremities. The scar should be large enough to separate the areas with a minimum of two centimeters.
- BMI > 22 and enough abdominal fat for a minor liposuction.
- Ability to understand information about the project.
- Significant comorbidities or lack of cognitive abilities to follow instructions.
- Not being able to participate due to language or other personal issues.
- Contraindications for abdominal liposuction.
- Pregnancy or breastfeeding
- Current or previous steroid therapy (systemic or local) within one year.
- Scar revision surgery within one year in the affected areas.
- Keloids.
- Active cancer or previous cancer within two years (skin cancers do not apply).
- Penicillin and Streptomycin allergy.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.